Sfoglia per AUTORE
DI MAIO M
Collezione AOU San Luigi di Orbassano

  

Items : 104

2025
ASL Torino 3
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bommart S; Tselikas L; Fonio P; Veltri A; De Baère T; Busso M; Guerrera F; Di Maio M; Balbi M; Monnin-Bares V; Gazzera C; Cignini V; Deschamps F; Di Chio A; Vanoverschelde J; Bonnet B; Menchini F; Zarqane H; Pujol JL; Yevich S; Brino J; Calandri M;

Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2025 Feb;23(1):102255. doi: 10.1016/j.clgc.2024.102255. Epub 2024 Nov 1.
2025
ASL Asti
AOU San Luigi di Orbassano

Cinieri S; Di Maio M; Tucci M; De Giorgi U; Russo A; Caffo O; Di Stefano RF; Turco F; Poletto S; Calabrese M; Saporita I; Buttigliero C;

Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2024 Sep;27(3):385-392. doi: 10.1038/s41391-023-00775-y. Epub 2023 De
2024
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Cathomas R; Tombal B; Smith MR; Fizazi K; Treglia G; Turco F; Gillessen S; Di Maio M; Vogl UM; Tucci M; Buttigliero C; Di Maio M; Cathomas R; Tombal B; Smith MR; Fizazi K; Treglia G; Gillessen S; Turco F; Tucci M; Vogl UM;

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Oct;22(5):102138. doi: 10.1016/j.clgc.2024.102138. Epub 2024 Jun 12.
2024
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Scagliotti GV; Di Maio M; Palesandro E; Poletto S; Calabrese M; Saporita I; Crespi V; Di Stefano RF; Farinea G; Fossati N; Gallina A; Zilli T; Vogl UM; Buttigliero C; Delcuratolo MD; Gillessen S; Turco F;

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13
2024
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Maio M; Novello S; Vellani G; Sperone P; Vignani F; Dionisio R; Ferrari G; Paratore C; Valsecchi AA;

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Planchard D; Besse B; Novello S; Barlesi F; Le Péchoux C; Facchinetti F; Aldea M; Genova C; Bironzo P; Di Maio M; Remon J; Tagliamento M; Tagliamento M; Di Maio M; Remon J; Bironzo P; Genova C; Facchinetti F; Aldea M; Le Péchoux C; Novello S; Barlesi F; Besse B; Planchard D;

Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study. in Cancers / Cancers (Basel). 2024 Feb 26;16(5):946. doi: 10.3390/cancers16050946.
2024
AOU San Luigi di Orbassano

Mussa MV; Allegra S; Armando T; Storto S; Ghezzo B; Soave G; Abbadessa G; Chiara F; Di Maio M; Dagnoni FM; De Francia S;

Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy. in Cancer / Cancer. 2023 Jun 1;129(11):1662-1671. doi: 10.1002/cncr.34731. Epub 2023 Mar 11.
2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Di Maio M; Righi L; Passiglia F; Listì A; Napoli VM; Jacobs F; Cani M; Bironzo P; Scagliotti GV;

2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Passiglia F; Novello S; Gianetta M; Di Maio M; D'Amiano C; Capelletto E; Bianco V; Bertaglia V; Napoli VM; Leone G; Cecchi C; Audisio A; Turco F; Delcuratolo MD; Cetoretta V; Pisano C; Parlagreco E; Garbo E; Ferrari G; Del Rio B; Cani M; Persano I; Scagliotti GV; Bironzo P;

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24
2023
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Brusa F; Audisio A; Di Stefano RF; Ungaro A; Audisio M; Samuelly A; Turco F; Tucci M; Delcuratolo MD;

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.
2023
ASL Cuneo 2
AO Cuneo
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Liello R; Di Maio M; Perrone F; Fabi A; Tuninetti V; Turco F; Trastu F; Reale ML; Paratore C; Lombardi P; Marandino L; Mariniello A; Ghisoni E; Gargiulo P; Bungaro M; Caglio A; Gamba T; Rossi A; Audisio M; Aimar G;

2023
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Parlagreco E; Ungaro A; Audisio M; Audisio A; Samuelly A; Pisano C; Urban S; Tucci M; Angusti T; Parente A; Di Stefano RF; Turco F; Turco F; Tucci M; Angusti T; Parente A; Di Stefano RF; Urban S; Pisano C; Samuelly A; Audisio A; Audisio M; Parlagreco E; Ungaro A; Scagliotti GV; Di Maio M; et alii...

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study. in BMJ oncology / BMJ Oncol. 2023 Mar 2;2(1):e000021. doi: 10.1136/bmjonc-2022-000021. eCollection 2023.
2023
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Turco F; Perrone F; Tuninetti V; Rossi A; Paratore C; Gargiulo P; Gamba T; Di Liello R; Caglio A; Audisio M; Bungaro M; Reale ML; Aimar G; Mariniello A; Lombardi P; Ghisoni E; Di Maio M; Trastu F; Marandino L;

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sangiolo D; Righi L; Passiglia F; Di Maio M; Paratore C; Bungaro M; De Filippis M; Consito L; Mecca C; Bertaglia V; Carnio S; Capelletto E; Listì A; Reale ML; Rezmives NA; Tesauro M; Indellicati D; Tabbò F; Mariniello A; Novello S; Geuna M; Bironzo P;

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bria E; Rossi G; Rossi A; Di Maio M; Bareggi C; Osman G; Cortinovis D; Cappuzzo F; Del Conte A; Pilotto S; Sergi C; Gregorc V; Ghilardi L; Scotti V; Tiseo M; Martelli O; Maiello E; Rigutto A; Galetta D; Castellana S; Trombetta D; Gobbini E; Muscarella LA; Tabbò F; Volante M; Scagliotti GV; Graziano P; Novello S; Righi L; et alii...

Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial. in International journal of cancer / Int J Cancer. 2022 Nov 15;151(10):1760-1769. doi: 10.1002/ijc.34156. Epub 2022 Jun 23.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Morano F; Pietrantonio F; Di Maio M; Di Bartolomeo M; Rossi A; Giordano M; Antonuzzo L; Petrelli F; Ratti M; Berenato R; Clavarezza M; Zaniboni A; Murialdo R; Tampellini M; Fanchini L; Antoniotti C; Bozzarelli S; Sartore-Bianchi A; Lonardi S; Pagani F; Randon G; Prisciandaro M; Raimondi A;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11
2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Di Stefano RF; Parlagreco E; Tucci M; Audisio M;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Porzio G; Tiseo M; Russano M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Metro G; Migliorino MR; Passiglia F; Ricciardi S; Zoratto F; Pecci F; Di Marino P; Mansueto G; De Tursi M; Tuzi A; Gori S; Della Gravara L; Macerelli M; Rastelli F; Chiari R; Gelibter A; Marchetti P; Antonuzzo L; Mazzoni F; et alii...

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Procopio G; Verzoni E; De Braud FG; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Buttigliero C; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Santini D; Casadei C; Buti S; De Giorgi U; Mennitto A; Zattarin E; Di Maio M; Bimbatti D;

2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Delcuratolo MD; Turco F; Di Prima L; Pisano C; Audisio A; Tucci M; Ungaro A;

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Reale ML; Perrone F; Mariniello A; Gargiulo P; Gamba T; Di Liello R; Caglio A; Bungaro M; Audisio M; Zichi C; Paratore C; Di Maio M;

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.
2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; DI Maio M; Tucci M; Scagliotti GV; Pisano C; Samuelly A; Turco F; Parente A; Bungaro M; DI Stefano RF; Angusti T;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.
2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Buttigliero C; Di Maio M; Ortega C; Ungaro A; Audisio M; Pisano C; Audisio A; Di Stefano RF; Tucci M; Delcuratolo MD; Turco F;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19
2022
ASL Asti
AOU San Luigi di Orbassano

Passiglia F; Novello S; Buffoni L; Carnio S; Capelletto E; Zichi C; Reale ML; Artusio E; Olmetto E; Bungaro M; Paratore C; Bertaglia V; Audisio M; Rapetti SG; Pignataro D; Curcio H; De Luca E; Bironzo P; Tagliamento M; Scagliotti GV; Di Maio M;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Bartolomeo M; Pietrantonio F; Di Maio M; Morano F; Corallo S; Berenato R; Ratti M; Clavarezza M; Zaniboni A; Murialdo R; Tampellini M; Ritorto G; Raimondi A; Fucà G; Leone AG; Lonardi S; Antoniotti C; Smiroldo V; Amatu A;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Scagliotti GV; Bussolino F; Di Maio M; Righi L; Passiglia F; Listì A; Caglio A; Sperone T; Tabbò F; Reale ML; Bironzo P;

Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:49-60. doi: 10.1016/j.ejca.2021.03.007. Epub 2021 Apr 3.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Perrone F; Gamba T; Caglio A; Bungaro M; Audisio M; Reale ML; Gargiulo P; Mariniello A; Di Maio M; Zichi C; Paratore C;

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Addeo A; Friedlaender A; Banna GL; Di Maio M; Spinelli GP; Russo A; Adamo V; De Filippis M; Metro G; Simona C; Natalizio S; Migliorino MR; Landi L; Ricciardi S; Buti S; Minuti G; Nigro O; Cantini L; Bracarda S; Citarella F; Russano M; Filetti M; Zoratto F; Gori S; De Tursi M; Mansueto G; Rocco D; et alii...

Synaptophysin expression in (V600EBRAF-)mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:145-154. doi: 10.1016/j.ejca.2021.01.016. Epub 2021 Feb 16.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Loupakis F; Dei Tos AP; Di Maio M; Zagonel V; Lonardi S; Biason P; Borga C; Centonze G; Santini D; Salmaso R; Salvatore L; Aprile G; Calvetti L; Smiroldo V; Rimassa L; Cortiula F; De Maglio G; Morano F; Boccaccino A; Bergamo F; Volante M; Zichi C; Dell'Aquila E; Sperti E; Pella N; Pietrantonio F; Schirripa M; Cremolini C; Maddalena G; et alii...

Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.
2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Pisano C; Audisio M; Bungaro M; Tucci M; Di Stefano RF; Samuelly A; Turco F;

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cortellini A; Mazzaschi G; Tiseo M; Pinato DJ; Carmisciano L; Ficorella C; Porzio G; Cannita K; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Adamo V; Russo A; Olmetto E; Metro G; Landi L; Ricciardi S; Migliorino MR; Tabbò F; Minuti G; Tuzi A; Bisonni R; Follador A; Gelibter A; Siringo M; Signorelli D; De Toma A; Garassino MC; et alii...

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27
2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Pisano C; Tucci M; Di Stefano RF; Turco F; Scagliotti GV; Di Maio M;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Di Maio M; Passiglia F; Capelletto E; Boccuzzi A; Caramello V; Olmetto E; Persano I; De Filippis M; Pisano C; Bironzo P; Mariniello A;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.
2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Bungaro M; Vignani F; Samuelly A; DI Stefano RF; Turco F; Tucci M; Pisano C;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Porzio G; Cannita K; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Ricciardi S; Migliorino MR; Landi L; Minuti G; Tuzi A; Bordi P; Russano M; Cantini L; Santini D; Citarella F; Zoratto F; Filetti M; Mansueto G; Di Marino P; Grassadonia A; Inno A; et alii...

2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Tucci M; Gamba T; Necchi A; Buttigliero C; Vignani F; Marandino L;

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baldessari C; Novello S; Bartoli G; Pizzutilo EG; Landi L; Dall'Olio FG; Toschi L; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Bearz A; Camerini A; Sala E; Migliorino MR; Cerea G; Ardizzoni A; Bennati C; Vita E; Del Conte A; Rossi S; Scotti V; Pilotto S; Cecere FL; Proto C; Berardi R; Mazzoni F; et alii...

Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2020 Mar;59(3):315-319. doi: 10.1080/0284186X.2019.1672891. Epub 2019 Oct 4.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Di Maio M; Muratori L; Brizzi MP; Trevisi E; Parisi F; La Salvia A; Atzeni F;

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Novello S; Di Maio M; Tiseo M; Galetta D; Bria E; Rossi G; Tabbò F; Cortinovis D; Rizzo P; Delmonte A; Bareggi C; Del Conte A; Sergi C; Casartelli C; Gregorc V; Graziano P; Rossi A; Maiello E; Scotti V; Martelli O; Borra G; Riccardi F; Osman G; Cappuzzo F; Cecere F; Pilotto S; Ghilardi L; Bordi P; Gobbini E; et alii...

Neuroendocrine breast carcinoma: a rare but challenging entity. in Medical oncology (Northwood, London, England) / Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; De Rosa G; Daniele L; Brizzi MP; La Salvia A; Trevisi E; Di Maio M;

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Aglietta M; Perrone F; Novello S; Bironzo P; Sonetto C; Muratori L; La Salvia A; Leone G; Trevisi E; Mariniello A; Pignataro D; Di Stefano RF; Ghisoni E; Zichi C; Lombardi P; Marandino L; De Luca E; Reale ML; Di Maio M;

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Novello S; Aglietta M; Leone F; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; Zichi C; De Luca E; Marandino L; Lombardi P; Perrone F; Di Maio M;

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.
2020
AOU Alessandria
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Numico G; Scagliotti GV; Guglielmini P; Lacidogna G; Turco F; Pisano C; Vignani F; Di Stefano RF; Tucci M; Sonetto C; Buttigliero C;

Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients. in Recenti progressi in medicina / Recenti Prog Med. 2020 Dec;111(12):740-748. doi: 10.1701/3509.34965.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Polimeno L; Pozzi D; Fusco L; Florio S; Codegone F; Comite R; Chiotto P; Ciriolo G; Audisio M; Ballaminut D; Bellezza A; Zichi C; De Luca E; Vignani F; Sperti E; Lacidogna G; Turco CGC; Guida G; Baratelli C; Marino D; Zilio E; Terzolo S; Di Maio M;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24
2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Di Maio M; Scagliotti GV; Vignani F; Tabbò F; Turco F; Di Stefano RF; Buttigliero C; Pisano C; Leone G;

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M; Raimondi A; Di Maio M; et alii...

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Dicorato AM; Verusio C; Giordano P; Gernone A; Prati V; Carnio S; Corbo C; Tassinari D; Cavanna L; Meriggi F; Iannopollo M; Sartori D; Longo L; Pezzuolo D; Bonetti A; Mucciarini C; Bracarda S; Fornarini G; Battelli N; Russo A; Lacidogna G; Zucali PA; Sorarù M; Banzi M; Negrini G; Cinieri S; Fratino L; Zustovich F; Mencoboni M; et alii...

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Aglietta M; Tucci M; Buttigliero C; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; Lombardi P; Zichi C; De Luca E; Marandino L; Scagliotti GV; Perrone F; Di Maio M;

Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report. in In vivo (Athens, Greece) / In Vivo. 2019 Nov-Dec;33(6):2021-2026. doi: 10.21873/invivo.11699.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Zichi C; Parra HS; Giajlevra M; Gelibter A; Cecere F; Barbieri F; Del Conte A; Chiari R; Catino A; Righi L; Ghisoni E; Mariniello A; Valabrega G; Novello S;

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment. in Gynecologic oncology reports / Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May.
2019
AOU San Luigi di Orbassano

Muratori L; Gorzegno G; Sperone P; Andreozzi A; Di Maio M; Scagliotti GV;

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. in Cancer treatment reviews / Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Veccia A; Rossetti S; Rizzo M; Maines F; Kinspergher S; Di Maio M; Cavaliere C; D'aniello C; Buttigliero C; Tucci M; Caffo O; Facchini G;

Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.
2019
AOU San Luigi di Orbassano

Muratori L; La Salvia A; Sperone P; Di Maio M;

Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy. in Future oncology (London, England) / Future Oncol. 2019 Jul;15(21):2543-2553. doi: 10.2217/fon-2018-0772. Epub 2019 Jun 26.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Locati LD; Di Giannantonio V; Sbrana A; Musettini G; Sonetto C; Bironzo P; Botta L; Bossi P; Di Maio M; Antonuzzo A;

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2019 Dec;27(12):4697-4704. doi: 10.1007/s00520-019-04777-2. Epub 2019 Apr 4.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Polimeno L; Fusco L; Florio S; Codegone F; Comite R; Ciriolo G; Chiotto P; Bellezza A; Ballaminut D; Audisio M; De Luca E; Zichi C; Marino D; Vignani F; Sperti E; Lacidogna G; Turco CGC; Baratelli C; Pozzi D; Zilio E; Terzolo S; Di Maio M;

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Riganti C; Scagliotti GV; Papotti M; Di Maio M; Novello S; Righi L; Ruffini E; Bussolino F; Ardissone F; Comunanza V; Passone E; Cartia CF; Tabbò F; Ananthanarayanan P; Bironzo P; Gagliasso M; Milosevic V; Costardi L; Maletta F; Salaroglio IC; Kopecka J; Napoli F; Pradotto M;

Capecitabine plus temozolomide in well- or moderately-differentiated primary atypical neuroendocrine tumours - single-centre experience of two cases. in Endokrynologia Polska / Endokrynol Pol. 2019;70(4):380-383. doi: 10.5603/EP.a2018.0076. Epub 2018 Oct 25.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Trevisi E; Muratori L; Brizzi MP; La Salvia A; Scagliotti GV;

Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:124-132. doi: 10.1016/j.critrevonc.2018.07.004. Epub 2018 Jul 1
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Ardizzoni A; Zichi C; Gatto L; Vignani F; Tucci M; Buttigliero C; De Luca E; Di Nunno V; Massari F;

Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. in Cancer treatment reviews / Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Maio M; Filippi AR; Scagliotti GV; Ruo Redda MG; Ricardi U; Di Stefano RF; Leone G; Zichi C; Allis S; Tucci M; Buttigliero C; Buttigliero C; Allis S; Tucci M; Zichi C; Leone G; Di Stefano RF; Ruo Redda MG; Ricardi U; Scagliotti GV; Di Maio M; Filippi AR;

A review of guidelines for lung cancer. in Journal of thoracic disease / J Thorac Dis. 2018 May;10(Suppl 13):S1556-S1563. doi: 10.21037/jtd.2018.03.54.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Bironzo P;

Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment? in Future oncology (London, England) / Future Oncol. 2018 May;14(12):1223-1231. doi: 10.2217/fon-2017-0627. Epub 2018 Apr 27.
2018
AOU San Luigi di Orbassano

Tampellini M; Bironzo P; Di Maio M; Scagliotti GV;

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2018 Mar;19(2):191-198. doi: 10.1016/j.cllc.2017.10.012. Epub 2017 Oct 28.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sperduti I; Aglietta M; Cagnazzo C; Di Stefano TS; Di Costanzo A; Matocci R; Chiari R; Petrillo P; Galetta D; Arizio F; Di Maio M; Polo V; Pasello G; Pilotto S; Gobbini E; Bria E; Novello S; Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; et alii...

Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;

A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tampellini M; Scagliotti GV; Brizzi MP; Sonetto C; Di Maio M; Zichi C; Baratelli C;

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Aglietta M; Novello S; Bironzo P; Marcato M; Muratori L; Leone G; Trevisi E; Reale ML; Mariniello A; Lombardi P; Ghisoni E; Di Stefano RF; Zichi C; Pignataro D; De Luca E; Sonetto C; La Salvia A; Marandino L; Scagliotti GV; Perrone F; Di Maio M;

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.
2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mazzaferro V; Buzzoni R; Delle Fave G; Giacomelli L; Milione M; Lo Russo G; Concas L; Femia D; Prinzi N; Garattini SK; Bajetta E; Tafuto S; Di Costanzo F; Torniai M; Zaniboni A; Ortolani S; Puliafito I; Panzuto F; Colao A; Brighi N; La Salvia A; Cavalcoli F; Bongiovanni A; Fazio N; Ricci S; Duro M; Davì MV; Cauchi C; Carnaghi C; et alii...

Hormonal treatment and quality of life of prostate cancer patients: new evidence. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2018 Apr;70(2):144-151. doi: 10.23736/S0393-2249.17.03066-1. Epub 2017 Dec 14.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Scagliotti GV; Pignataro D; Vignani F; DI Stefano RF; Zichi C; Leone G; Buttigliero C; Tucci M;

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sperti E; Marcato M; Bria E; Vignani F; Bironzo P; Baratelli C; Di Maio M; Roila F;

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression. in International journal of clinical oncology / Int J Clin Oncol. 2018 Apr;23(2):281-286. doi: 10.1007/s10147-017-1195-x. Epub 2017 Sep 27.
2018
AOU San Luigi di Orbassano

Baratelli C; Tampellini M; Di Maio M; Ottone A; Brizzi MP; Forti L; Alabiso I; Sonetto C; Alabiso O; Scagliotti GV; Baratelli C; Tampellini M; Di Maio M; Ottone A; Brizzi MP; Forti L; Alabiso I; Sonetto C; Alabiso O; Scagliotti GV;

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions. in OncoTargets and therapy / Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Vignani F; Buttigliero C; Zichi C; Tucci M; Di Maio M;

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Novello S; Maiello E; Catino A; Cortinovis D; Pisconti S; Bordi P; Migliorino MR; Franchina T; Delmonte A; Ceribelli A; Buffoni L; Riccardi F; Scotti V; Rossi G; Gregorc V; Bria E; Di Maio M; Rossi A; Graziano P; Arizio F; Tiseo M; Galetta D; Gobbini E; Gobbini E; Galetta D; Tiseo M; Graziano P; Rossi A; Bria E; et alii...

Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer. in Expert review of respiratory medicine / Expert Rev Respir Med. 2017 Mar;11(3):171-180. doi: 10.1080/17476348.2017.1290526. Epub 2017 Feb 9.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; La Salvia A; Rossi A;

Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. in Cancer treatment reviews / Cancer Treat Rev. 2017 Mar;54:1-9. doi: 10.1016/j.ctrv.2017.01.002. Epub 2017 Jan 11.
2017
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Vignani F; Scagliotti GV; Di Maio M;

Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysis. in Clinical lung cancer / Clin Lung Cancer. 2017 Jan;18(1):23-33.e1. doi: 10.1016/j.cllc.2016.08.006. Epub 2016 Oct 28.
2017
AOU San Luigi di Orbassano

La Salvia A; Rossi A; Galetta D; Gobbini E; De Luca E; Novello S; Di Maio M;

Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis. in Breast (Edinburgh, Scotland) / Breast. 2017 Feb;31:114-120. doi: 10.1016/j.breast.2016.10.021. Epub 2016 Nov 9.
2017
AOU San Luigi di Orbassano

Bonotto M; Gerratana L; Di Maio M; De Angelis C; Cinausero M; Moroso S; Milano M; Stanzione B; Gargiulo P; Iacono D; Minisini AM; Mansutti M; Fasola G; De Placido S; Arpino G; Puglisi F;

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Fontanini G; Di Maio M; Milione M; Volpi C; Fucà G; Sensi E; Tamburini E; Tampellini M; Baratelli C; Zucchelli G; Busico A; Gloghini A; Rossini D; Perrone F; Tamborini E; Berenato R; Morano F; Moretto R; Cremolini C; De Braud F; Falcone A; Pietrantonio F;

Can intercalating chemotherapy with epidermal growth factor receptor inhibitors delay development of treatment resistance in advanced non-small cell lung cancer? in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2017 Dec;18(18):1899-1902. doi: 10.1080/14656566.2017.1409721. Epub 2017 N
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Rossi A; De Luca E; La Salvia A;

Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit. in Clinical colorectal cancer / Clin Colorectal Cancer. 2017 Dec;16(4):372-376. doi: 10.1016/j.clcc.2017.03.019. Epub 2017 Apr 8.
2017
AOU San Luigi di Orbassano

La Salvia A; Sonetto C; Brizzi MP; Anania L; Baratelli C; Di Maio M; Tampellini M; Scagliotti GV;

An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Scagliotti GV; Aroasio E; Buttigliero C; Berruti A; Bertaglia V; Tucci M; Vignani F;

Zoledronic Acid Dosing Interval for Metastatic Cancer. in JAMA / JAMA. 2017 Apr 11;317(14):1477-1478. doi: 10.1001/jama.2017.2562.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Buttigliero C; Tucci M;

Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias? in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Apr 10;35(11):1264. doi: 10.1200/JCO.2016.69.3580. Epub 2017 Feb 6.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Vignani F; Tucci M; Buttigliero C;

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. in BioMed research international / Biomed Res Int. 2017;2017:5618174. doi: 10.1155/2017/5618174. Epub 2017 Jun 7.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Pignataro D; Vignani F; Buttigliero C; Leone G; Tucci M; Zichi C; Di Maio M;

Measuring the Real Clinical Impact of Randomized Clinical Trials in Oncology: Beyond Citation Counts. in JAMA oncology / JAMA Oncol. 2016 Nov 1;2(11):1510-1511. doi: 10.1001/jamaoncol.2016.1779.
2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tampellini M; Baratelli C; Di Maio M;

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. in Nature reviews. Clinical oncology / Nat Rev Clin Oncol. 2016 May;13(5):319-25. doi: 10.1038/nrclinonc.2015.222. Epub 2016 Jan 20.
2016
AOU San Luigi di Orbassano

Di Maio M; Basch E; Bryce J; Perrone F;

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 May;95:73-81. doi: 10.1016/j.lungcan.2016.02.011. Epub 2016 Feb 26.
2016
AOU San Luigi di Orbassano

Vavalà T; Follador A; Tiseo M; Galetta D; Morabito A; Di Maio M; Martelli O; Caffo O; Piovano PL; Cortinovis D; Zilembo N; Casartelli C; Banna GL; Ardizzoia A; Barzelloni ML; Bearz A; Genestreti G; Mucciarini C; Filipazzi V; Menis J; Rizzo E; Barbieri F; Rijavec E; Cecere F; Bria E; Spitaleri G; Rossi A; Novello S;

Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2016 Mar;44:61-73. doi: 10.1016/j.ctrv.2016.02.002. Epub 2016 Feb 12.
2016
AOU San Luigi di Orbassano

Vignani F; Bertaglia V; Buttigliero C; Tucci M; Scagliotti GV; Di Maio M;

Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2016 Jun;16(6):653-60. doi: 10.1586/14737140.2016.1170596. Epub 2016 Apr
2016
AOU San Luigi di Orbassano

Rossi A; Di Maio M;

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Jun;5(3):301-21. doi: 10.21037/tlcr.2016.06.10.
2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Rossi G; Bria E; Graziano P; Di Maio M; Tiseo M; Facchinetti F;

Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Feb;5(1):89-91. doi: 10.3978/j.issn.2218-6751.2015.07.18.
2016
AOU San Luigi di Orbassano

Di Maio M; Bironzo P; Scagliotti GV;

2016
AOU San Luigi di Orbassano

Tampellini M; Gned D; Baratelli C; Brizzi MP; Ottone A; Alabiso I; Bertaggia C; Di Maio M; Scagliotti GV; Veltri A;

Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis. in European urology / Eur Urol. 2016 Apr;69(4):563-573. doi: 10.1016/j.eururo.2015.09.013. Epub 2015 Sep 28.
2016
AOU San Luigi di Orbassano

Scagliotti GV; Porpiglia F; Fiori C; Buttigliero C; Vignani F; Tucci M; Bertaglia V; Di Maio M;

Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2016 Apr;11(4):504-15. doi: 10.1016/j.jtho.2016.01.004. Epub 2016 Jan 13.
2016
AOU San Luigi di Orbassano

Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M;

Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy. in Analytical cellular pathology (Amsterdam) / Anal Cell Pathol (Amst). 2016;2016:4918325. doi: 10.1155/2016/4918325. Epub 2016 Dec 18.
2016
AOU San Luigi di Orbassano

Cavalcanti E; Barchiesi V; Cerasuolo D; Di Paola F; Cantile M; Cecere SC; Pignata S; Morabito A; Costanzo R; Di Maio M; Perrone F;

2016
AOU San Luigi di Orbassano

Moretti A; Ghidini M; De Angelis C; Lambertini M; Cremolini C; Imbimbo M; Berardi R; Di Maio M; Cascinu S; La Verde N;

Tivantinib added to erlotinib in nonsmall-cell lung cancer: the primary end point was not MET... in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Oct;26(10):2007-9. doi: 10.1093/annonc/mdv334. Epub 2015 Aug 11.
2015
AOU San Luigi di Orbassano

Scagliotti GV; Di Maio M;

2015
AOU San Luigi di Orbassano

Brizzi MP; Sonetto C; Tampellini M; Di Maio M; Volante M; Scagliotti GV;

2015
AOU San Luigi di Orbassano

Barni S; Maiello E; Di Maio M; Ardizzoni A; Cappuzzo F; Maranzano E; Novello S; Bennati C; Ori A; Rizzoli S; Crinò L;

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Jun;88(3):319-24. doi: 10.1016/j.lungcan.2015.03.016. Epub 2015 Apr 1.
2015
AOU San Luigi di Orbassano

Buti S; Bordi P; Tiseo M; Bria E; Sperduti I; Di Maio M; Panni S; Novello S; Rapetti SG; Pilotto S; Genestreti G; Rossi A; Pezzuolo D; Camisa R; Tortora G; Ardizzoni A;

LUX-Lung: determining the best EGFR inhibitor in NSCLC? in The Lancet. Oncology / Lancet Oncol. 2015 Feb;16(2):118-9. doi: 10.1016/S1470-2045(14)71196-9. Epub 2015 Jan 12.
2015
AOU San Luigi di Orbassano

Rossi A; Di Maio M;

Subgroup Analysis: Refining a Positive Result or Trying to Rescue a Negative One? in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2015 Dec 20;33(36):4310. doi: 10.1200/JCO.2015.62.6747. Epub 2015 Sep 21.
2015
AOU San Luigi di Orbassano

Di Maio M; Perrone F;

BRAF-mutated metastatic colorectal cancer between past and future. in British journal of cancer / Br J Cancer. 2015 Dec 1;113(11):1634-5. doi: 10.1038/bjc.2015.316. Epub 2015 Sep 10.
2015
AOU San Luigi di Orbassano

Cremolini C; Di Maio M; Petrelli F; Berenato R; Loupakis F; Pietrantonio F;

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31.
2015
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Bertaglia V; Vignani F; Bironzo P; Di Maio M; Scagliotti GV;

2015
AOU San Luigi di Orbassano

Vincenzi B; Di Maio M; Silletta M; D'Onofrio L; Spoto C; Piccirillo MC; Daniele G; Comito F; Maci E; Bronte G; Russo A; Santini D; Perrone F; Tonini G;

Maintenance therapy in NSCLC: why? To whom? Which agent? in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2011 May 6;30(1):50. doi: 10.1186/1756-9966-30-50.
2011
AOU San Luigi di Orbassano

Novello S; Milella M; Tiseo M; Banna G; Cortinovis D; Di Maio M; Garassino M; Maione P; Martelli O; Vavalà T; Bria E;